Biểu đồ giá cổ phiếu BMY
BMY Giá
Bristol-Myers Squibb Co
$55.67
-0.87%
$-0.48
Khi đóng cửa: May 11, 16:00:00 GMT-4
$56.32
1.17%
$0.65
Phiên trước giờ: May 12, 05:03:26 GMT-4
Quay lại
Bristol-Myers Squibb Co (BMY) Giá
Thống kê chính
Giá đóng cửa trước
$56.16
Giá mở cửa
$56.27
Phạm vi ngày
$55.4 - $56.49
Phạm vi 52 tuần
$42.52 - $62.88
Khối lượng
8.3M
Khối lượng trung bình
13.4M
Tỷ suất cổ tức
4.26%
EPS (TTM)
3.46
Vốn hóa thị trường
$114.9B
BMY là gì?
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The company is headquartered in Princeton, New Jersey and currently employs 32,500 full-time employees. The company is engaged in the discovery, development and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its growth portfolio includes Opdivo (nivolumab), Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), Yervoy (ipilimumab), Reblozyl (luspatercept-aamt), Opdualag (nivolumab and relatlimab-rmbw), Breyanzi (lisocabtagene maraleucel), Camzyos (mavacamten), Zeposia (ozanimod), Abecma (idecabtagene vicleucel), and Sotyktu (deucravacitinib). Its other growth products include Onureg, Inrebic, and Empliciti. Its legacy portfolio includes Eliquis (apixaban), Revlimid (lenalidomide), Pomalyst/Imnovid (pomalidomide), Sprycel (dasatinib), and Abraxane (paclitaxel albumin-bound particles for injectable suspension). Opdivo (nivolumab) is a fully human monoclonal antibody that binds to the PD-1 on T and NKT cells.
